The diagnostic value of human epididymis protein 4 as a novel biomarker in patients with renal dysfunction
Authors:
- 13 July 2018
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 50 (11) , 2043-2048
Abstract
In this study, we investigated the diagnostic value of human epididymis protein 4 (HE4) in acute and chronic renal dysfunction and analyzed the correlation between HE4 levels and the results of routine renal function tests. We aimed to provide evidence to establish HE4 as a novel biomarker of renal injury and its appropriate application as a marker of ovarian cancer.Keywords
This publication has 20 references indexed in Scilit:
- HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart FailureJournal of Cardiac Failure, 2017
- Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern ChinaClinica Chimica Acta, 2016
- The correct renal function evaluation in patients with thyroid dysfunctionJournal of Endocrinological Investigation, 2015
- Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian massesBMC Cancer, 2013
- Myofibroblasts, regeneration or renal fibrosis--is there a decisive hint?Nephrology Dialysis Transplantation, 2013
- Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 2013
- The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart FailureJACC: Heart Failure, 2013
- Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosisNature Medicine, 2013
- Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiencyKidney International, 2002
- Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomasGene, 1999